YTHDF2 Antikörper (AA 201-500) (FITC)
Kurzübersicht für YTHDF2 Antikörper (AA 201-500) (FITC) (ABIN7175944)
Target
Alle YTHDF2 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
- 
    - 
                                            Bindungsspezifität
- AA 201-500
- 
                                            Kreuzreaktivität
- Human
- 
                                            Aufreinigung
- >95%, Protein G purified
- 
                                            Immunogen
- Recombinant Human YTH domain-containing family protein 2 protein (201-500AA)
- 
                                            Isotyp
- IgG
 
- 
                                            
- 
    
- 
    - 
                                            Beschränkungen
- Nur für Forschungszwecke einsetzbar
 
- 
                                            
- 
    - 
                                            Format
- Liquid
- 
                                            Buffer
- 
                        Preservative: 0.03 % Proclin 300
 Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4
- 
                                            Konservierungsmittel
- ProClin
- 
                                            Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- 
                                            Lagerung
- -20 °C,-80 °C
- 
                                            Informationen zur Lagerung
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
 
- 
                                            
- 
    - YTHDF2 (YTH Domain Family, Member 2 (YTHDF2))
- 
                                            Andere Bezeichnung
- YTHDF2
- 
                                            Hintergrund
- 
                        Background: Specifically recognizes and binds N6-methyladenosine (m6A)-containing RNAs, and regulates mRNA stability (PubMed:24284625, PubMed:26046440). M6A is a modification present at internal sites of mRNAs and some non-coding RNAs and plays a role in the efficiency of mRNA splicing, processing and stability (PubMed:22575960, PubMed:24284625, PubMed:25412658, PubMed:25412661). Acts as a regulator of mRNA stability: binding to m6A-containing mRNAs results in the localization to mRNA decay sites, such as processing bodies (P-bodies), leading to mRNA degradation (PubMed:24284625, PubMed:26046440). Aliases: 9430020E02Rik antibody, CAHL antibody, CLL associated antigen KW 14 antibody, CLL-associated antigen KW-14 antibody, HGRG8 antibody, High glucose regulated protein 8 antibody, High-glucose-regulated protein 8 antibody, NY REN 2 antibody, Renal carcinoma antigen NY REN 2 antibody, Renal carcinoma antigen NY-REN-2 antibody, YTH domain family 2 antibody, YTH domain family member 2 antibody, YTH domain family protein 2 antibody, YTH N6 methyladenosine RNA binding protein 2 antibody, YTHD2_HUMAN antibody, YTHDF 2 antibody, YTHDF2 antibody 
- 
                                            UniProt
- Q9Y5A9
 Target
- 
                    
 
                                     
                                     
                                    